Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-05

Clinical Trial Update: Using Intranasal Midazolam (INM) and Lidocaine for Uncooperative Children [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating intranasal midazolam and lidocaine for uncooperative children with burning nose symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)
  • intranasal Midazolam (midazolam)

Snippet

Sponsor: Tishreen University | Conditions: Burning Nose | Phase 2, Phase 3 | Status: COMPLETED